Eidos Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Eidos Therapeutics, Inc. Website Screenshot

http://www.eidostx.com

Eidos Therapeutics, Inc. Company Intro

Targeting TTR amyloidosis at its source. Transthyretin (TTR) amyloidosis is a family of rare, devastating diseases with serious unmet medical needs.

Industry

Healthcare

Eidos Therapeutics, Inc. Headquaters

101 Montgomery Street
San Francisco,94104
United States


Eidos Therapeutics, Inc. Share price

28 Oct 2020 01:32 GMT

$73.49

0.22 (0.3 %)


Eidos Therapeutics, Inc. Market cap

$2.832 B


WMC RANKING

2020

Eidos Therapeutics, Inc. # 115

Biotechnology



Latest Eidos Therapeutics, Inc. News

News 27 Oct 2020

Analysts Mean recommendation for Front Yard Residential Corporation (RESI) was 2.40: Is this the key time?

... Companies: Eidos Therapeutics, Inc. (NASDAQ:EIDX), BioSpecifics Technologies Corp. (NASDAQ:BSTC), Front Yard Residential Corporation (NYSE:RESI).

News 27 Oct 2020

Analysts Mean recommendation for Front Yard Residential Corporation (RESI) was 2.40: Is this the key time?

... Companies: Eidos Therapeutics, Inc. (NASDAQ:EIDX), BioSpecifics Technologies Corp. (NASDAQ:BSTC), Front Yard Residential Corporation (NYSE:RESI).

News 26 Oct 2020

Transthyretin amyloidosis space heats up with a potential cure

San Francisco-based Eidos Therapeutics Inc. is looking to go head-to-head with Pfizer with its own TTR stabilizer, acoramidis. Screening for the company's pivotal ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Eidos Therapeutics, Inc. 0.48 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.31 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.32 26 0 0 97.51
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.19 100 0 0 90.89

Eidos Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Eidos Therapeutics, Inc. $26,691 $64,642 $-37,835 $2.828B 115
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.467B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $53.956B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.394B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.779B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Eidos Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Eidos Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries